Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer

NCT07570524 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer (TNBC)

Interventions

BIOLOGICAL: Additionnal breast biospy and blood sample

Sponsor

Center Eugene Marquis